77%[1] of respondents define health as "living independently and doing what's important", prioritizing a meaningful life over simply living longer. Many would prefer a fulfilling life to age 75 over living to 80 in an ordinary manner—reflecting a shift in how longevity is traditionally perceived. Resilience across physical, financial, and mental well-being—alongside strong family support—is key to aging well. With health issues to emerge as early as age 39 on average among respondents, the three most anticipated areas of increased spending are medication (43%), major illnesses and
MILAN, July 17, 2025 -- A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when nearly 4 million patients across about 60 countries worldwide were treated with this drug. Conducted by Italian researchers and supported by NTC, the study analyzed public safety data registered in
밀라노, 2025년 7월 17일 -- 최근 발표된 5년간의 약물감시 시험에서 NTC가 개발한 항염증성 스테로이드와 퀴놀론계 항생제가 함유된 고정용량 병용 점안제가 탁월한 안전성을 보이는 것으로 확인됐다. 특히 성인의 백내장 수술 후 염증 예방 및 치료와 감염 예방에 적합하다. 이 시험은 약 60개국에서 약 400만 명의 환자가 이 약물을 사용한 데이터를 기반으로 이루어졌다. 이탈리아 연구진이 수행하고 NTC의 지원을 받은 이 시험은 유럽 의약품청(European Medicines Agency)의 공식 약물 부작용(ADR) 데이터베이스인 EudraVigilance에서 안전성 보고서를 수집하는 adrreports.eu 포털에 등록된 공공 안전 데이터를 분석했다. 이 시험에서 2020년과 2024년 사이 해당 약물과 관련된 ADR은 총 25명의 환자에서 53건만 보고됐다. 주요 결과는 다음과 같다. ADR의 74%는 중대하지 않았다. 절반 이상이 해당 약물과 관련성이 낮은 것으로 판단됐다. 가장 빈번하게 보고된 사례는 눈 또는 피부와 관련된 경미한 반응으로, 이는 국소 투여되는 안과용 점안액에서 예상 가능한 결과로 여겨진
KUALA LUMPUR, Malaysia, July 17, 2025 -- In celebration of World Microbiome Day, SpaceGut, a Malaysia-based health tech company, introduces a scientific and personalised approach to one of the country's most pressing health concerns, obesity. Through its Gut Microbiome Test Kit and AI-powered personalised meal plan, SpaceGut aims to address the root microbial imbalances that contribute to excessive weight gain and metabolic disorders. Obesity in Malaysia has become an increasingly serious public health concern. According to the National Health and Morbidity Survey (NHMS) 2023,
SINGAPORE, July 17, 2025 -- At the Growth Asia Summit 2025, which took place from July 15–17 in Singapore, Vinamilk was honored to be the only Vietnamese company invited as a keynote speaker. The Growth Asia Summit is the largest forum for growth opportunities in the food, beverage, and nutrition industries in Asia. The brand made a remarkable impression with its innovative 6-HMO infant formula, setting a new standard in pediatric nutrition and paving the way for the dairy industry in Asia. Vinamilk's presence at the Summit is symbolic; it reflects the nation's transformation f
[ 메디채널 김갑성 기자 ] 선전, 중국 2025년 7월 17일 -- 화웨이(Huawei)가 '2025 글로벌 교육 및 의료 파트너 중국 컨벤션(2025 Global Education and Healthcare Partner China Convention)'을 개최했다. 이번 행사에는 40개국에서 300명 이상의 협력사 관계자들이 참석했다. 이 자리에서 화웨이는 글로벌 교육 및 헬스케어 파트너 연합(Global Education and Healthcare Partner Alliance, GEHPA)을 공식 출범했다. 연합은 업계 파트너들과의 소통을 강화하고, 상호 강점을 결합해 상생 협력을 도모하며, 궁극적으로는 고품질의 지속 가능한 산업 생태계 구축을 목표로 한다. GEHPA 참여 기관들은 공동으로 기술 연구를 수행하고, 혁신적인 솔루션을 개발해 전 세계 교육 및 의료 분야의 디지털 전환을 가속할 수 있을 것으로 기대된다. AI 기술과 애플리케이션이 급속도로 발전하면서 교육과 의료 분야에 큰 영향을 미치고 있다. 화웨이 엔터프라이즈 영업부 파트너 개발 및 상업•유통 사업부 어니스트 장(Ernes
YONGIN, South Korea, July 17, 2025 -- GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from the Drug Administration of Vietnam (DAV). Following domestic approval in 2020 and WHO Pre-Qualification (PQ) in 2023, GC Biopharma has been accelerating individual country registrations as part of its dual-track strategy—pursuing both global procurement channels and direct market entry initiatives. To obtain approval in Vietnam, GC Biopharma conducted local clinical tri
TOKYO, July 17, 2025 -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1 billion (USD 7.3 million1) in four R&D projects for the development of vaccine, drug, and diagnostics for malaria and tuberculosis (TB).2 Investment of JPY 800 million (USD 5.5 million1) in malaria vaccine project Malaria is a serious infectious disease that affects more than 260 million people and claims approximately 600,000 lives worldwide each year. Over 90% of all malaria cases occur in Africa, with more than 70% of those affected being c
SINGAPORE, July 17, 2025 -- Guardian, Singapore's #1 trusted health and wellness retailer, today announced the launch of its new mobile application, bringing a more convenient and rewarding way for customers to shop their health, beauty and wellness essentials. Designed to connect the in-store offline and online shopping experience, the Guardian app places the retailer's comprehensive curation of health, beauty and wellness solutions right at customers' fingertips. Customers can easily browse from thousands of health, beauty and wellness products from vitamins and supp
SHANGHAI, July 17, 2025 -- CPHI & PMEC China 2025 concluded in June with a record-breaking 109,056 attendees, fostering meaningful connections across the entire pharmaceutical supply chain. This remarkable success is a testament to the strong demand within China's thriving pharma industry. Building on this momentum, CPHI & PMEC Shenzhen 2025 will take place from 1-3 September 2025 at Shenzhen Exhibition & Convention Center (SZCEC), addressing the growing demand for access to South China's key pharma markets. As a key gateway to the Guangdong-Hong Kong-Macau Greater